Member Info for JohnHenry

Chart primed for when seller is cleared.

But at £ 350 million MKT CAP looks fully valued even with the cash pile.

sold at a loss 3 minutes later. AIM market at present full of Bedwetters.

Obelix imho the market hasnt a clue where to value NCYT on a forward looking basis.

No idea of number left however likely to be fairly low. Seems Acacia elected to dump through the market on a daily basis until cleared.

At present the SP is squeezed tightly between the 8 and 50 moving averages. When the ACACIA lid is lifted the SP is going to break higher very quickly. aimho

Will be interesting to hear his Comments about ACACIA as its looking like they are still in the market.

Huge potential going forward.

220p-230p 225p mid SP very very weak. After showing a little momentum after filling the 217p gap its looking like the technicals will fill the 192p gap, the 124p gap looks safe for now.

Thats not the inhaler link .

Davey that was highlighted the other day, REMD not covered within the patent. Gilead are free to use any inhaler delivery device of their choosing.

Very much so Swervington, the fact they havent and the low market volume would suggest they are not involved.

Slicevolley, spot on. i would say a lot of recent spin from Friel concerning the placing and Acacia . FinnCap simply havent engaged.

Company had expected mining difficulty to drop 4-6% instead it rising and just posted its largest two week increase in 12 months.

Rickmeister a stock warrant is nothing like a convertible loan.

IF they dont convert the warrants they loose nothing.

The warrants are bonus sweetner attached with the note.

Conversion rate set when you buy ??? explain.

105p offer, going to be a lot of churn. lot of profit from 35p. warrants are they from the CLNs if so they will be sold imho.

short term the SP will have to deal with another 1.8M shares overhanging the market as can be seen by todays weakness. Aimho

As you can see by the open on Nasdaq pre trade price means diddly squat.